OAinject: Fighting osteoarthritis

In the Netherlands, more than 1.5 million people suffer from osteoarthritis – a chronic degenerative rheumatic condition of the joints that causes pain, stiffness and restriction in daily moving. As osteoarthritis is a condition that mainly occurs among older people, the number of patients is set to greatly increase due to the ageing of Dutch society. At present, there is no adequate treatment for osteoarthritis.

osteoarthritis

Maastricht University is part of the OAinject consortium, funded by the Perspectief program of the Dutch Research Council (NWO), that will develop new diagnostic tools to determine which form of osteoarthritis a patient has. This way more accurate individualised treatments can be offered in the future. The researchers will also work on innovative ways of gradually administering drugs locally over a extended period of time via an injectable drug depot in the diseased joint. With this approach, the consortium aims to develop novel methods that are expected to support a durable active lifestyle for osteoarthritis patients.

Our CAPHRI/ MUMC+ researchers Tim Welting and Pieter Emans from the Department of Orthopedic Surgery are co-initiator and member of the OAinject project. The project is led by Marcel Karperien of the University of Twente.

Consortium

Programme leader: Prof. Marcel Karperien (University of Twente)
Participating knowledge institutions: Delft University of Technology, Erasmus MC, Maastricht University, Maastricht University Medical Center, Radboud university medical center, University Medical Center Utrecht, University of Twente
Companies: Chondropeptix, DSM Biomedical, IBIS Technologies, InnoCore Pharmaceuticals, 20Med Therapeutics, Nordic Bioscience, Orthros Medical, Procore, QVQ, Ssens
Other societal partners: Deventer Hospital, ReumaNederland, Dutch Society for the Replacement of Animal Testing

Video

Also read

  • Scientists at the biomedical MERLN Institute of Maastricht University and the Maastricht University Medical Center have succeeded in growing an embryo structure of human identical twins purely from stem cells, without using an egg or sperm cell. Thanks to this culture, scientists are now seeing for...

  • Students at our faculty are committed to making an impact on health, well-being and society. Among them is Angelica, a master’s student in Health Education and Promotion who is an expert by experience on the impact well-formulated advice can have on a person’s life.

  • On February 8, 2024, Ziemons received her PhD from Maastricht University for the dissertation “The role of the gut microbiota in human cancer, the power of an equilibrium". This dissertation is the result of Ziemons' research on the role of the microbiota in cancer – colorectal cancer but also...